Representative before the EPO

Company dna zacco gmbh
no operation time available
770.68
Headquarter in M√ľnchen and 1 office
active in Legal Services

Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Carsten Dietmar Prusko has worked on the following 4 EPO patent applications which have been published in the last five years:

EP12734417

USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER

IPC classification:
A61K 38/16, A61P 37/04
Agent:
Anna-Louise Hally, F. R. Kelly & Co.
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Carsten Dietmar Prusko, Zacco GmbH
Status:
GRANT OF PATENT INTENDED
EP13817006

LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 38/00, A61K 39/00, A61P 35/00, C07K 14/47, C07K 16/44, C12N 5/0783, C12N 15/09
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco GmbH
Status:
EXAMINATION IN PROGRESS
EP13817533

CDCA1 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 38/00, A61K 39/00, A61P 35/00, C07K 14/47, C07K 16/44, C12N 5/0783, C12N 15/09
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco GmbH
Status:
EXAMINATION IN PROGRESS
EP13816244

KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 38/00, A61K 39/00, A61P 35/00, C07K 14/47, C07K 16/44, C12N 5/0783, C12N 15/09
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco GmbH
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature